{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T12:40:10Z","timestamp":1648903210231},"reference-count":50,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.mehy.2014.04.018","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T10:31:18Z","timestamp":1398508278000},"page":"16-20","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A new hypothesis on preventable neuropsychiatric illness in Africa"],"prefix":"10.1016","volume":"83","author":[{"given":"Gregor","family":"Pollach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Namboya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2014.04.018_b0005","unstructured":"Ministry of Health. Malawi Standard Treatment Guidelines (MSTG). Ministry of Health, 2009; 4th Edition."},{"key":"10.1016\/j.mehy.2014.04.018_b0010","unstructured":"Cook GC, Zumla A (ed.), Manson\u2019s Tropical Diseases. 21 ed. Saunders; 2003: 1291."},{"key":"10.1016\/j.mehy.2014.04.018_b0015","unstructured":"British National Formulary. 55, Informations on praziquantel, mefloquin, ciprofloxacin, efavirenz. Ed.: 2009."},{"key":"10.1016\/j.mehy.2014.04.018_b0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1351\/pac198855020409","article-title":"Revision of the extended Hantzsch\u2013Widmann system of nomenclature for Heteromonocycles","volume":"55","author":"Moss","year":"1983","journal-title":"Pure Appl Chem"},{"key":"10.1016\/j.mehy.2014.04.018_h0025","article-title":"Neurotoxicity of quinoline-related anti-infectives an underestimated burden of the health care systems in Africa?","author":"Pollach","year":"2013","journal-title":"Gesundheits\u00f6konomie Qualit\u00e4tsmanagement"},{"key":"10.1016\/j.mehy.2014.04.018_h0030","unstructured":"(b) Ministry of Health; Malawi Standard Treatment Guidelines, ((MSTG), Ministry of, Health, 2009, 4th Edition."},{"key":"10.1016\/j.mehy.2014.04.018_h0035","article-title":"Quinine, an old anti-malarial drug in a modern world role in the treatment of malaria","author":"Achan","year":"2013","journal-title":"Malaria"},{"key":"10.1016\/j.mehy.2014.04.018_b0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4615-0135-0_14","article-title":"Neurokynurenines (NEKY) as com mon neurochemical links of stress and anxiety","volume":"527","author":"Lapin","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.mehy.2014.04.018_b0035","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00115-007-2311-3","article-title":"Immunological aspects of depressive disorders","volume":"78","author":"M\u00fcller","year":"2007","journal-title":"Nervenarzt"},{"key":"10.1016\/j.mehy.2014.04.018_b0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity","volume":"10","author":"Wichers","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.mehy.2014.04.018_b0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mehy.2013.10.026","article-title":"5-HTP hypothesis of schizophrenia","volume":"82","author":"Fukuda","year":"2014","journal-title":"Med Hypothesis"},{"key":"10.1016\/j.mehy.2014.04.018_h0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/jama.1990.03450030017002","article-title":"AIDS dementia may be linked to metabolite of tryptophan","volume":"264","author":"Cotton","year":"1990","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2014.04.018_h1060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jns.2011.07.021","article-title":"Altered tryptophan metabolism in Parkinson\u2019s disease a possible novel therapeutic approach","volume":"310","author":"Szab\u00f3","year":"2011","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.mehy.2014.04.018_h0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1203\/PDR.0b013e3181eee738","article-title":"Cerebral malaria; mechanisms of brain injury and strategies for improved neuro-cognitive outcome","volume":"68","author":"Idro","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1016\/j.mehy.2014.04.018_h0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2007-979191","article-title":"Possible use of amantadine in depression","volume":"32","author":"Huber","year":"1999","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.mehy.2014.04.018_h0080","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1176\/appi.ajp.162.7.1385","article-title":"Anti depressant effect of ketamine during ECT","volume":"162","author":"Ostroff","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2014.04.018_b0055","unstructured":"Wikipedia commons, the free media repository; 5.4.2009, last access: 11.2.2014."},{"key":"10.1016\/j.mehy.2014.04.018_b0060","unstructured":"Edwinophilus: The Kynurenine pathway; Wikipedia commons, the free media repository; 5.4.2009, last access: 11.2.2014."},{"key":"10.1016\/j.mehy.2014.04.018_b0065","unstructured":"Peter J.-U. Genetic and pharmacological manipulation of the tryptophan hydroxylasis; PhD, Free University of Berlin, 2006 www.diss.fu-berlin.de\/diss\/servlets\/MCRFileNodeServlet\/FUDISS, last accessed: 11.2.2014."},{"key":"10.1016\/j.mehy.2014.04.018_b0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0304-3940(01)02242-X","article-title":"Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia","volume":"131","author":"Erhardt","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2014.04.018_b0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410290215","article-title":"Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status","volume":"29","author":"Heyes","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2014.04.018_b0080","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1096\/fasebj.12.10.881","article-title":"Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques","volume":"12","author":"Heyes","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2014.04.018_b0085","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","article-title":"Cytokine-serotonin inter action through IDO: a neurodegeneration hypo thesis of depression","volume":"61","author":"Myint","year":"2003","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2014.04.018_b0090","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0889-1591(02)00006-5","article-title":"Neopterin production tryptophan degradation and mental depression\u2013what is the link?","volume":"16","author":"Widner","year":"2002","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.mehy.2014.04.018_b0095","first-page":"41","article-title":"Brain serotonin and epileptic seizures in mice: a pharmacological and biochemical study","volume":"30","author":"Kostowski","year":"1978","journal-title":"Pol J Pharmacol Pharm"},{"key":"10.1016\/j.mehy.2014.04.018_b0100","series-title":"Serotoninergic Neurons and 5-HT Receptors in the CNS","article-title":"Role of serotonergic neurons and 5-HT receptors in the action of hallucinogens","author":"Nichols","year":"2000"},{"issue":"5884","key":"10.1016\/j.mehy.2014.04.018_b0105","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.1155577","article-title":"Serotonin modulates behavioral reactions to unfairness","volume":"320","author":"Crockett","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.mehy.2014.04.018_b0110","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha interleukin 6 and interferon-gamma production by peripheral blood mononuclear cells","volume":"24","author":"V d Borne","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.mehy.2014.04.018_b0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.physbeh.2007.05.025","article-title":"The kynurenic acid hypothesis of schizophrenia","volume":"92","author":"Erhardt","year":"2007","journal-title":"Physiol Behav"},{"key":"10.1016\/j.mehy.2014.04.018_b0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4137\/IJTR.S12536","article-title":"Kynurenic acid in the digestive system\u2014new facts, new challenges","volume":"6","author":"Turski","year":"2013","journal-title":"Int J Tryptophan Res"},{"key":"10.1016\/j.mehy.2014.04.018_b0125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1365-2249.1999.00910.x","article-title":"Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells","volume":"116","author":"Weiss","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.mehy.2014.04.018_b0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.fob.2012.08.004","article-title":"Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC","volume":"6","author":"Gostner","year":"2012","journal-title":"FEBS Open Bio"},{"issue":"1\u20133","key":"10.1016\/j.mehy.2014.04.018_b0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0378-4274(01)00509-4","article-title":"Clinical toxicological aspects of fluoroquinolones","volume":"127","author":"Stahlmann","year":"2002","journal-title":"TToxicil Lett"},{"key":"10.1016\/j.mehy.2014.04.018_b0140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tmaid.2008.12.004","article-title":"Mefloquine neurotoxicity: a literature review","volume":"7","author":"Toovey","year":"2009","journal-title":"Travel Med Infect Dis"},{"issue":"10","key":"10.1016\/j.mehy.2014.04.018_b0145","doi-asserted-by":"crossref","first-page":"e25525","DOI":"10.1371\/journal.pone.0025525","article-title":"Praziquantel facilitates IFN-\u03b3-producing CD8+ T cells (Tc1) and IL-17-producing CD8+ T cells (Tc17) responses to DNA vaccination in mice","volume":"6","author":"Zou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2014.04.018_b0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/exnr.1999.7135","article-title":"NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization","volume":"159","author":"Chen","year":"1999","journal-title":"Exp Neurol"},{"issue":"22","key":"10.1016\/j.mehy.2014.04.018_b0155","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0024-3205(00)00546-4","article-title":"Role of cytochrome P450 3A in the metabolism of mefloquine in human and animal hepatocytes","volume":"66","author":"Fontaine","year":"2000","journal-title":"Life Sci"},{"issue":"8","key":"10.1016\/j.mehy.2014.04.018_b0160","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J"},{"issue":"7","key":"10.1016\/j.mehy.2014.04.018_b0165","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mehy.2014.04.018_b0170","doi-asserted-by":"crossref","unstructured":"M\u00f6ller H-J, M\u00fcller N, editors. Aktuelle Aspekte der Pathogenese und Therapie der Schizophrenie. Springer, 2005, pp. 108.","DOI":"10.1007\/3-211-29109-1"},{"issue":"3","key":"10.1016\/j.mehy.2014.04.018_b0175","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1124\/jpet.106.101923","article-title":"Mefloquine enhances nigral gamma-aminobutyric acid release via inhibition of cholinesterase","volume":"317","author":"Zhou","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20133","key":"10.1016\/j.mehy.2014.04.018_b0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainresbull.2006.07.011","article-title":"The connexin 36 blockers quinine, quinidine and mefloquine inhibit cortical spreading depression in a rat neocortical slice model in vitro","volume":"71","author":"Margineanu","year":"2006","journal-title":"Brain Res Bull"},{"issue":"33","key":"10.1016\/j.mehy.2014.04.018_b0185","doi-asserted-by":"crossref","first-page":"12364","DOI":"10.1073\/pnas.0402044101","article-title":"Potent block of Cx36 and C50 gap junction channels by mefloquine","volume":"101","author":"Cruikshank","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2014.04.018_b0190","unstructured":"Shepard RD, Fletcher A. Use of (+) \u2013 mefloquine for the treatment of malaria with reduced side-effects. Int Patent Appl WO 1998; 9839003."},{"key":"10.1016\/j.mehy.2014.04.018_b0195","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/01.qai.0000147523.41993.47","article-title":"Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence","volume":"38","author":"Fumaz","year":"2005","journal-title":"J Acquir Immun Defic Syndr"},{"key":"10.1016\/j.mehy.2014.04.018_b0200","unstructured":"Peden M, Scurfield, R, Sleet D, Mohan D, Hyder AA, Jarawan E, Mathers C. World Report on Traffic Injury Prevention, WHO 2004."},{"key":"10.1016\/j.mehy.2014.04.018_b0205","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.103.049700","article-title":"Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration","volume":"306","author":"Salzberg-Brenhouse","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2014.04.018_b0210","first-page":"1","article-title":"Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms","volume":"5","author":"Prez-Cruz","year":"2012","journal-title":"Int J Tryptophan Res"},{"issue":"5","key":"10.1016\/j.mehy.2014.04.018_b0215","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/339009","article-title":"The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria","volume":"185","author":"Medana","year":"2002","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.mehy.2014.04.018_b0220","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1086\/377583","article-title":"Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of malawian children with malaria","volume":"188","author":"Medana","year":"2003","journal-title":"J Infect Dis"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714001674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987714001674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T18:41:49Z","timestamp":1565376109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987714001674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0306987714001674"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2014.04.018","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new hypothesis on preventable neuropsychiatric illness in Africa","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2014.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}